Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Cardiovascular disease risk factors and cognitive impairment.

Nash DT, Fillit H.

Am J Cardiol. 2006 Apr 15;97(8):1262-5. Epub 2006 Mar 3. Review.

PMID:
16616038
2.

Cardiovascular risk factors and dementia.

Fillit H, Nash DT, Rundek T, Zuckerman A.

Am J Geriatr Pharmacother. 2008 Jun;6(2):100-18. doi: 10.1016/j.amjopharm.2008.06.004. Review.

PMID:
18675769
3.
4.

Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.

Panza F, Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Palasciano R, Todarello O, Capurso S, Pellicani V, Capurso A.

Aging Clin Exp Res. 2006 Apr;18(2):144-8. Review.

PMID:
16702784
5.

Optimal medical management of peripheral arterial disease.

Rice TW, Lumsden AB.

Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review.

PMID:
16959725
6.

Diabetes mellitus and dementia.

Pasquier F, Boulogne A, Leys D, Fontaine P.

Diabetes Metab. 2006 Nov;32(5 Pt 1):403-14. Review.

PMID:
17110895
7.

Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.

Pregelj P.

Psychiatr Danub. 2008 Jun;20(2):162-7. Review.

PMID:
18587285
8.

[The best of epidemiology and cardiovascular prevention in 2006].

Thomas D, Collet JP, Cottin Y, Cournot M, Ducimetière P, Ferrières J, Paillard F, Valensi P, Zeller M, Cambou JP.

Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:57-64. Review. French.

PMID:
17405566
9.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7. Review.

PMID:
18427276
11.

[What are the possibilities of preventing dementia?].

Krajcík S.

Vnitr Lek. 2003 Mar;49(3):234-40. Review. Slovak.

PMID:
12728599
12.

Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.

Staels B, Maes M, Zambon A.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):542-53. doi: 10.1038/ncpcardio1278. Epub 2008 Jul 15. Review.

PMID:
18628776
13.

Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.

Rojas-Fernandez CH, Moorhouse P.

Ann Pharmacother. 2009 Jul;43(7):1310-23. doi: 10.1345/aph.1L703. Epub 2009 Jul 7. Review.

PMID:
19584390
14.

[Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors].

Siqueira AF, Almeida-Pititto Bd, Ferreira SR.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):257-67. Review. Portuguese.

15.

Cardiovascular disease. A men's health hazard.

Foreman MD.

Nurs Clin North Am. 1986 Mar;21(1):65-73. Review.

PMID:
3513134
16.

[Cardiovascular risk factors. I. Review of possible causes of heart and vascular diseases].

van der Bom JG, Bots ML, Grobbee DE.

Ned Tijdschr Geneeskd. 2002 Jun 22;146(25):1169-74. Review. Dutch.

PMID:
12109306
17.

Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.

Poon IO.

Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366. Review.

PMID:
18294116
18.

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Nordestgaard BG, Zacho J.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. doi: 10.1016/j.numecd.2009.07.005. Epub 2009 Aug 19. Review.

PMID:
19695857
19.

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus.

Riche DM, McClendon KS.

Am J Health Syst Pharm. 2007 Aug 1;64(15):1603-10. Review.

PMID:
17646562
20.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Review.

PMID:
18480348

Supplemental Content

Support Center